Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
2005
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade
2007
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
2018 Standout
A comprehensive review of the genetics of juvenile idiopathic arthritis
2008
Optical coherence tomography angiography
2017 Standout
American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis
2011 Standout
Predictors of disease course and remission in systemic juvenile idiopathic arthritis: Significance of early clinical and laboratory features
2006
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
Medical Treatment of Juvenile Idiopathic Arthritis
2005
NF-κB signaling in inflammation
2017 Standout
Estudio epidemiológico de artritis idiopática juvenil en el Principado de Asturias: presentación de la casuística en los últimos dieciséis años
2007
Foreign body reaction to biomaterials
2008 Standout
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling
2009
Autoinflammatory Disease Reloaded: A Clinical Perspective
2010 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
2009
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
2007
International research networks in pediatric rheumatology: the PRINTO perspective
2004
Juvenile idiopathic arthritis
2007 Standout
Chemokines and disease
2001
Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis
2004
Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
2018
The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients
2007
TFOS DEWS II pathophysiology report
2017 Standout
The use of anakinra in juvenile arthritis
2005
TGF-β Type II Receptor/MCP-5 Axis: At the Crossroad between Joint and Growth Plate Development
2012
Sensors of the innate immune system: their link to rheumatic diseases
2010 StandoutNobel
Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations
2004
Serum levels of insulin-like growth factor I and its binding proteins in health and disease
2003
Physical fitness in childhood and adolescence: a powerful marker of health
2007 Standout
Ectopic lymphoid tissues and local immunity
2008
Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study
2004
How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets
2008
Caspase Functions in Cell Death and Disease
2013 Standout
Adipokines: inflammation and the pleiotropic role of white adipose tissue
2004 Standout
Macrophage migration inhibitory factor: a regulator of innate immunity
2003 Standout
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
2015
Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study
2006
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Anakinra Therapy in a Child With Systemic-Onset Juvenile Rheumatoid Arthritis After Human Herpesvirus 6 Encephalitis
2006
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation
2011
TFOS DEWS II Management and Therapy Report
2017 Standout
Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
2008
Exercise, stress, and inflammation in the growing child: from the bench to the playground
2004
Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia
2002
T cell migration in rheumatoid arthritis
2015
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Anti–tumor necrosis factor-α therapy in uveitis
2015
Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
2013 Standout
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+memory T cells homing to the joints in juvenile idiopathic arthritis
2005
Patterns of clinical remission in select categories of juvenile idiopathic arthritis
2005
Current management of juvenile idiopathic arthritis
2006
Chemokine gene polymorphisms in idiopathic anterior uveitis
2006
Uveitis associated with childhood rheumatic diseases
2002
Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
2007
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register
2008
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
The Many Roles of Chemokines and Chemokine Receptors in Inflammation
2006 Standout
A novel 5′‐flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic‐onset juvenile idiopathic arthritis
2001
Targeting the interleukin‐6 receptor: A new treatment for systemic juvenile idiopathic arthritis?
2005
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Early predictors of outcome in juvenile idiopathic arthritis.
2004
Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.
2004
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis
2002
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia
2012 StandoutNobel
Regulation of Interleukin 8 Production and Gene Expression in Human Adipose Tissue in Vitro1
2001
TNF‐mediated inflammatory disease
2007 Standout
Benefit/risk of cyclosporine in rheumatoid arthritis.
2005
Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
2005
Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis
2007
Works of V. Gerloni being referenced
Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
2002
Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup.
2003
Rituximab Treatment For Juvenile Idiopathic Arthritis Associated Uveitis
2011
Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients
2007
Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10‐year prospective study
2001
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors
2007
Assessment of damage in juvenile‐onset systemic lupus erythematosus: A multicenter cohort study
2003
Long-term Treatment with Golimumab for Severe Uveitis
2013
Efficacy of repeated intravenous infusions of an anti–tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open‐label prospective study
2005
Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration
2006
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
2012
Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)
2011
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis
2011
Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
1999
Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.
2000
Combination therapy of juvenile rheumatoid arthritis with hydroxychloroquine-gold-methotrexate: a pilot study.
1994
Preliminary evidence that etanercept may reduce radiographic progression in juvenile idiopathic arthritis.
2009
Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.
1998
A multicenter study on insulin-like growth factor-I serum levels in children with chronic inflammatory diseases.
1998